A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Best Buy Father's Day Sale: Save on Sonos, Microsoft Surface, Apple Gift Cards, More
EU blesses transatlantic data sharing deal
Acer Swift Go 16 Review
Tesla shouldn't call driving system Autopilot because humans are still in control, Buttigieg says
Ryder Named Among Food Logistics’ Top 3PL & Cold Storage Providers to Food & Beverage Industry for 11th Consecutive Year
Q4 Inc. Introduces First-of-its-Kind IR Event Management App to the Q4 Platform
Intel Hit by $400 Million Fine as Clash With EU Rumbles On
Wildfire Moves Closer to Athens on High Winds and Saharan Heat